Skip to main content

Japanese firm’s AI algorithm for gastric cancer gets FDA’s Breakthrough Device designation

The Food and Drug Administration has provided a Breakthrough Device Designation for AI Medical Service’s’ machine learning algorithm that has the ability to analyze endoscopy images for potential diagnosis of gastric cancer.

No Comments yet!

Your Email address will not be published.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2021 Esophageal Cancer Education Foundation